Methods
SIRS, aortic valve replacement
This is a randomized clinical trial with 24 patients submitted to isolated
aortic valve replacement divided into two groups: Perceval™ S (Group
P) and conventional bioprostheses (Group C). Incidence of severe SIRS (three
or more criteria) in the first 48 hours postoperatively, EMP release
profile, interleukins (IL) 6 and 8, C-reactive protein, and procalcitonin
were analyzed preand postoperatively at 24 hours and three months.